Erdönmez Dilek, Hatun Sükrü, Çizmecioğlu Filiz Mine, Keser Alev
Kocaeli University of Medical School, Pediatric Endocrinology and Diabetes Unit, Kocaeli, Turkey.
J Clin Res Pediatr Endocrinol. 2011;3(4):198-201. doi: 10.4274/jcrpe.507.
To investigate the effects of vitamin D deficiency on both insulin resistance and risk of metabolic syndrome in children.
The study group consisted of 301 children and adolescents with a mean age of 14.2 ± 1.8 years. Serum 25-hydroxyvitamin D [25(OH)D] levels and insulin resistance indices were evaluated. According to serum 25(OH)D levels, the subjects were classified in 3 groups. Those with levels ≤ 10 ng/mL were labeled as the vitamin D deficient group (group A), those with levels of 10-20 ng/mL as the vitamin D insufficient group (group B) and those with ≥ 20 ng/mL as having normal vitamin D levels (group C). Metabolic syndrome was defined according to the International Diabetes Federation consensus. The participants with and without metabolic syndrome were compared in terms of 25(OH)D levels.
Mean 25(OH)D level of the total group was 18.2 ± 9.3 (2.8-72.0) ng/mL. Distribution of individuals according to their vitamin D levels showed that 11.6% were in group A, 53.5% in group B, and 34.9% in group C. The proportions of boys and girls in these categories were 22.9% and 77.1% in group A, 36.6% and 63.4% in group B, 54.3% and 45.7% in group C, respectively. There were no significant differences in 25(OH)D levels in the individuals with and without impaired fasting glucose or impaired glucose tolerance. No relationship was observed between insulin resistance/sensitivity indices and vitamin D status (p > 0.05). Metabolic syndrome was diagnosed in 12.3% (n = 37) of the children. There was also no difference in mean 25(OH)D levels between individuals who had and those who did not have the metabolic syndrome.
In our study, no correlations were found between insulin measurements during oral glucose tolerance test and vitamin D deficiency. Nonetheless, more extended studies including vitamin D supplementation and evaluating insulin sensitivity via clamp technique are needed to further elucidate this relationship.
探讨维生素D缺乏对儿童胰岛素抵抗及代谢综合征风险的影响。
研究组由301名儿童和青少年组成,平均年龄为14.2±1.8岁。评估血清25-羟维生素D[25(OH)D]水平和胰岛素抵抗指数。根据血清25(OH)D水平,将受试者分为3组。25(OH)D水平≤10 ng/mL者标记为维生素D缺乏组(A组),10 - 20 ng/mL者为维生素D不足组(B组),≥20 ng/mL者为维生素D水平正常组(C组)。代谢综合征根据国际糖尿病联盟共识定义。比较有和没有代谢综合征的参与者的25(OH)D水平。
全组平均25(OH)D水平为18.2±9.3(2.8 - 72.0)ng/mL。根据维生素D水平对个体进行的分布显示,A组占11.6%,B组占53.5%,C组占34.9%。这些类别中男孩和女孩的比例在A组分别为22.9%和77.1%,B组分别为36.6%和63.4%,C组分别为54.3%和45.7%。空腹血糖受损或糖耐量受损的个体与未受损个体的25(OH)D水平无显著差异。未观察到胰岛素抵抗/敏感性指数与维生素D状态之间的关系(p>0.05)。12.3%(n = 37)的儿童被诊断为代谢综合征。有和没有代谢综合征的个体之间的平均25(OH)D水平也没有差异。
在我们的研究中,口服葡萄糖耐量试验期间的胰岛素测量值与维生素D缺乏之间未发现相关性。尽管如此,仍需要进行更广泛的研究,包括补充维生素D并通过钳夹技术评估胰岛素敏感性,以进一步阐明这种关系。